Activation mechanism of nuclear receptor CAR by xenobiotics and CAR-mediated disruption of energy metabolism
Project/Area Number |
23790104
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Biological pharmacy
|
Research Institution | Toho University |
Principal Investigator |
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2011: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
Keywords | 転写因子 / 分子生物学 / 代謝調節 / 核内受容体 / 環境衛生系薬学 / 環境毒性学 / 環境・衛生系薬学 / 薬学 |
Research Abstract |
The constitutive androstane receptor (CAR) plays an important role of a defence mechanism against the toxicity of xenobiotics. In this study, we identified novel CAR binding proteins, which were AMPKβ, DP97, PRMT5 and Hsp60. We showed DP97 and PRMT5 act as a gene (or promoter)-selective co-activators for CAR. Furthermore, we showed the basal transcriptional activity of unliganded CAR was shown to be repressed by the potent liver X receptor (LXR) agonist, T0901317
|
Report
(3 results)
Research Products
(30 results)